Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Assessing blood-brain barrier dysfunction and its association with Alzheimer’s pathology, cognitive impairment and neuroinflammation ; volume:16 ; number:1 ; day:31 ; month:7 ; year:2024 ; pages:1-12 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (31.7.2024), 1-12, 12.2024
- Creator
-
Preis, Lukas
Villringer, Kersten
Brosseron, Frederic
Düzel, Emrah
Jessen, Frank
Petzold, Gabor C.
Ramírez, Alfredo
Spottke, Annika
Fiebach, Jochen Benedikt
Peters, Oliver
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-024-01529-1
- URN
-
urn:nbn:de:101:1-2410250850528.236537969081
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Preis, Lukas
- Villringer, Kersten
- Brosseron, Frederic
- Düzel, Emrah
- Jessen, Frank
- Petzold, Gabor C.
- Ramírez, Alfredo
- Spottke, Annika
- Fiebach, Jochen Benedikt
- Peters, Oliver
- SpringerLink (Online service)
Other Objects (12)
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease
Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
Natural aging and Alzheimer’s disease pathology increase susceptibility to focused ultrasound-induced blood–brain barrier opening
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease
Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology
Natural aging and Alzheimer’s disease pathology increase susceptibility to focused ultrasound-induced blood–brain barrier opening
Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease
Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer’s pathology
Dimethyl fumarate improves cognitive impairment and neuroinflammation in mice with Alzheimer’s disease
Neuroinflammation is associated with Alzheimer’s disease co-pathology in dementia with Lewy bodies
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer’s disease animal model
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Microglial PD‐1 stimulation by astrocytic PD‐L1 suppresses neuroinflammation and Alzheimer’s disease pathology
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer’s disease
Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology